Zhang X, Xue H, Lv Y, Zhou Y, Sha K, Liu T
Discov Oncol. 2025; 16(1):320.
PMID: 40088344
DOI: 10.1007/s12672-025-02070-9.
Juthi R, Sazed S, Mareboina M, Zaravinos A, Georgakopoulos-Soares I
Int J Mol Sci. 2025; 26(5).
PMID: 40076932
PMC: 11899893.
DOI: 10.3390/ijms26052311.
Xu J, Cai X, Huang J, Huang H, Wang Y, Ji X
Int J Mol Sci. 2025; 26(5).
PMID: 40076546
PMC: 11899986.
DOI: 10.3390/ijms26051916.
Sears T, Wang W, Drumm M, Unruh D, McCord M, Horbinski C
Cancers (Basel). 2025; 17(5).
PMID: 40075681
PMC: 11898980.
DOI: 10.3390/cancers17050834.
Tang Y, Hu H, Chen S, Hao B, Xu X, Zhu H
Sci Rep. 2025; 15(1):8591.
PMID: 40074806
PMC: 11903666.
DOI: 10.1038/s41598-025-92700-7.
LST1 expression correlates with immune infiltration and predicts poor prognosis in acute myeloid leukemia.
Xu H, Chen D, Lu J, Wang L, Chen F, Zhong L
Discov Oncol. 2025; 16(1):305.
PMID: 40072762
PMC: 11904058.
DOI: 10.1007/s12672-025-02082-5.
Increasing RB1 Expression by Targeting EZH2 in Triple-Negative Breast Cancer.
Yang R, Fei L, Xue Y, Zhang Y, Hu Q, Guo L
J Cell Mol Med. 2025; 29(5):e70384.
PMID: 40070134
PMC: 11897054.
DOI: 10.1111/jcmm.70384.
Tumor cell-derived ISG15 promotes fibroblast recruitment in oral squamous cell carcinoma via CD11a-dependent glycolytic reprogramming.
Wang S, Chen Y, Huang S, Fu Y, Lin S, Jiang S
Oncogenesis. 2025; 14(1):6.
PMID: 40069143
PMC: 11897235.
DOI: 10.1038/s41389-025-00549-2.
RCE-IFE: recursive cluster elimination with intra-cluster feature elimination.
Kuzudisli C, Bakir-Gungor B, Qaqish B, Yousef M
PeerJ Comput Sci. 2025; 11:e2528.
PMID: 40062294
PMC: 11888879.
DOI: 10.7717/peerj-cs.2528.
Prognostic significance and immune microenvironment infiltration patterns of hypoxia and endoplasmic reticulum stress-related genes in gastric cancer.
Li L, Liang Y, Xu W
Front Oncol. 2025; 15:1542740.
PMID: 40061897
PMC: 11885130.
DOI: 10.3389/fonc.2025.1542740.
Micro-RNA-140-3p Acts as a Tumor Suppressor Gene in Acute Promyelocytic Leukemia by Targeting Hepatocyte Growth Factor.
Lei R, Liu X, Wu Y, Song J, Lv X, Liu J
Cell Biochem Biophys. 2025; .
PMID: 40057668
DOI: 10.1007/s12013-025-01707-4.
A novel glycolysis-related gene signature for predicting prognosis and immunotherapy efficacy in breast cancer.
Huang R, Li Y, Lin K, Zheng L, Zhu X, Huang L
Front Immunol. 2025; 16:1512859.
PMID: 40046063
PMC: 11880812.
DOI: 10.3389/fimmu.2025.1512859.
Multi-omics analysis identifies UBA family as potential pan-cancer biomarkers for tumor prognosis and immune microenvironment infiltration.
Wang H, Liu X, Huang H, Tang M, Li J, Huang T
Front Immunol. 2025; 16:1510503.
PMID: 40046044
PMC: 11880792.
DOI: 10.3389/fimmu.2025.1510503.
TCGEx: a powerful visual interface for exploring and analyzing cancer gene expression data.
Kus M, Sahin C, Kilic E, Askin A, Ozgur M, Karahanogullari G
EMBO Rep. 2025; .
PMID: 40033050
DOI: 10.1038/s44319-025-00407-7.
Deciphering FOXM1 regulation: implications for stemness and metabolic adaptations in glioblastoma.
Swati K, Arfin S, Agrawal K, Jha S, Rajendran R, Prakash A
Med Oncol. 2025; 42(4):88.
PMID: 40032774
DOI: 10.1007/s12032-025-02639-y.
Creation of an innovative diagnostic framework for hepatocellular carcinoma employing bioinformatics techniques focused on senescence-related and pyroptosis-related genes.
Liu B, Ao Y, Liu C, Bai F, Zhou Z, Huang J
Front Oncol. 2025; 15:1485421.
PMID: 40018411
PMC: 11864952.
DOI: 10.3389/fonc.2025.1485421.
Variability in radiotherapy outcomes across cancer types: a comparative study of glioblastoma multiforme and low-grade gliomas.
Veviorskiy A, Mkrtchyan G, Osipov A, Izumchenko E, Ozerov I, Aliper A
Aging (Albany NY). 2025; 17(2):550-562.
PMID: 40015963
PMC: 11892922.
DOI: 10.18632/aging.206212.
ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation.
Zhang J, Wang G, Liu J, Tang F, Wang S, Li Y
Front Oncol. 2025; 15:1513622.
PMID: 40012546
PMC: 11860100.
DOI: 10.3389/fonc.2025.1513622.
8q24 derived ZNF252P promotes tumorigenesis by driving phase separation to activate c-Myc mediated feedback loop.
Qu T, Zhang C, Lu X, Dai J, He X, Li W
Nat Commun. 2025; 16(1):1986.
PMID: 40011431
PMC: 11865308.
DOI: 10.1038/s41467-025-56879-7.
Thymidine kinase 1 indicates resistance to immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma.
Wang J, Xu X, Wang Y, Zhu Y
Cell Oncol (Dordr). 2025; .
PMID: 40009128
DOI: 10.1007/s13402-025-01048-7.